Risk of a contralateral breast cancer is associated with genetic susceptibility, such as germline BRCA1/2 mutation, or a strong family history of breast cancer and the decision to undergo CPM was associated with family history and cancer stage in our study, suggesting that uptake is partly related to risk factors. This evidence concerns the gene BRCA1 and breast carcinoma.